Rosalind group discloses 7% MediWound (MDWD) stake in Schedule 13G/A

Rhea-AI Filing Summary

MediWound Ltd. reported ownership by a Rosalind-affiliated group in a Schedule 13G/A. Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon together report beneficial ownership of 912,319 MediWound common shares, or 7% of the class, based on 12,835,186 shares outstanding as of January 16, 2026.

The filing explains that this figure includes 163,265 shares issuable upon exercise of warrants that are subject to a 9.99% ownership blocker. Excluding those blocked warrants, Rosalind Master Fund may be deemed to beneficially own 749,054 shares, or about 5.84% of the common stock. The group states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of MediWound.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 9)

MediWound Ltd.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

M68830104

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. M68830104

1

Names of Reporting Persons

Rosalind Advisors, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 912,319.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 912,319.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

912,319.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.0 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: This percentage is calculated based upon 12,835,186 shares of the Issuers common stock outstanding as of January 16, 2026, in accordance with Issuer's 6-K filed on January 15, 2026. However, as more fully described in Item 4, the securities reported in rows 6, 8, and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8, and 9. (6) 749,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants

SCHEDULE 13G

CUSIP No. M68830104

1

Names of Reporting Persons

SALAMON STEVEN A J

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 912,319.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 912,319.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

912,319.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (6) 749,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants

SCHEDULE 13G

CUSIP No. M68830104

1

Names of Reporting Persons

Aharon Gil

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 912,319.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 912,319.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

912,319.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (6) 749,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants

SCHEDULE 13G

CUSIP No. M68830104

1

Names of Reporting Persons

Rosalind Master Fund L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 912,319.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 912,319.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

912,319.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.0 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: (6) 749,054 shares of Common Stock 163,265 shares of Common Stock issuable upon exercise of warrants

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MediWound Ltd.
(b)	Address of issuer's principal executive offices: 42 HAYARKON STREET, 42 HAYARKON STREET, YAVNE, ISRAEL, 8122745
Item 2.
(a)	Name of person filing: Rosalind Advisors, Inc. Advisor to RMF Rosalind Master Fund L.P. RMF Steven Salamon President Steven Salamon is the portfolio manager of the Advisor which advises RMF. Gilad Aharon is the portfolio manager and member of the Advisor which advises RMF.
(b)	Address or principal business office or, if none, residence: Rosalind Advisors, Inc. 15 Wellesley Street West Suite 326 Toronto, Ontario M4Y 0G7 Canada Rosalind Master Fund L.P. P.O. Box 309 Ugland House, Grand Cayman KY1-1104, Cayman Islands Steven Salamon 15 Wellesley Street West Suite 326 Toronto, Ontario M4Y 0G7 Canada Gilad Aharon 15 Wellesley Street West Suite 326 Toronto, Ontario M4Y 0G7 Canada
(c)	Citizenship: Steven Salamon Ontario, Canada Gilad Aharon Ontario, Canada
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: M68830104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information as of the date of the event which requires filing of this statement required by Items 4a to c is set forth in Rows 7 to 13 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 13 of the cover page for each Reporting Person is based upon 12,835,186 shares of the Issuers common stock outstanding as of January 16, 2026, in accordance with Issuer's 6-K filed on January 15, 2026. Rosalind Master Fund L.P. may have been deemed to have the beneficial ownership of 749,054 shares of common stock representing the beneficial ownership of approximately 5.84% of the common stocks as mentioned above, which excludes the 163,265 shares issuable upon the exercise of warrants because they contain a blocker provision under which the holder thereof does not have the right to exercise any of the warrant to the extent that such exercise would result in beneficial ownership by the holder in excess of 9.99% of the Common Stock. Rosalind Advisors, Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF. Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF. Notwithstanding the foregoing, the Advisor and Mr. Salamon disclaim beneficial ownership of the shares.
(b)	Percent of class: Rosalind Advisors, Inc. 7% Rosalind Master Fund L.P. 7% Steven Salamon 7% Gilad Aharon 7%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: Rosalind Advisors, Inc. - 749,054 shares of Common Stock Rosalind Master Fund L.P. - 749,054 shares of Common Stock Steven Salamon - 749,054 shares of Common Stock Gilad Aharon - 749,054 shares of Common Stock
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: Rosalind Advisors, Inc. - 749,054 shares of Common Stock Rosalind Master Fund L.P. - 749,054 shares of Common Stock Steven Salamon - 749,054 shares of Common Stock Gilad Aharon - 749,054 shares of Common Stock
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Rosalind Advisors, Inc.

Signature:	Steven Salamon
Name/Title:	President
Date:	02/11/2026

SALAMON STEVEN A J

Signature:	Steven Salamon
Name/Title:	Steven Salamon
Date:	02/11/2026

Aharon Gil

Signature:	Aharon Gil
Name/Title:	Aharon Gil
Date:	02/11/2026

Rosalind Master Fund L.P.

Signature:	Mike McDonald
Name/Title:	Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:	02/11/2026

FAQ

What ownership stake does Rosalind Advisors report in MediWound (MDWD)?

Rosalind Advisors, Inc. reports beneficial ownership of 912,319 MediWound common shares, representing 7% of the class, based on 12,835,186 shares outstanding as of January 16, 2026. This includes shares underlying certain warrants that are subject to a 9.99% ownership blocker.

How many MediWound shares does Rosalind Master Fund L.P. beneficially own?

Rosalind Master Fund L.P. may be deemed to beneficially own 749,054 MediWound common shares, or approximately 5.84% of the outstanding stock. This percentage is calculated using 12,835,186 shares outstanding as of January 16, 2026, and excludes 163,265 warrant shares blocked by a 9.99% cap.

What is the warrant blocker provision mentioned in the MediWound Schedule 13G/A?

The warrants held by Rosalind Master Fund limit exercises if they would push ownership above 9.99% of MediWound’s common stock. Because of this blocker, 163,265 warrant shares are excluded from the 5.84% stake figure, even though they are counted in the 912,319 total beneficial shares.

Who are the reporting persons in the MediWound (MDWD) Schedule 13G/A amendment?

The reporting persons are Rosalind Advisors, Inc., Rosalind Master Fund L.P., and individuals Steven Salamon and Gilad Aharon. Rosalind Advisors acts as investment adviser to the fund, and Salamon and Aharon are portfolio managers who may be deemed beneficial owners of shares held by the fund.

Is Rosalind seeking control of MediWound according to this Schedule 13G/A?

No. The certification states the MediWound securities were acquired and are held in the ordinary course of business. It also states they were not acquired and are not held for the purpose of changing or influencing control of MediWound, except for limited director-nomination activities.